BridgeBio Pharma, Inc. (BBIO) Executive Team

Executive Team
FinancialsSegmentsShareholders

BridgeBio Pharma executive team at a glance

BridgeBio Pharma lists 10 executives, led by Neil Kumar Ph.D., Co-Founder, CEO & Director (age 46). Thomas Trimarchi Ph.D. is the company's CFO & President (age 40).

In fiscal year 2025 the highest-paid executive was Neil Kumar Ph.D., Co-Founder, CEO & Director, with total pay of $2.46 million. The 6 executives with reported pay received $6.64 million in all.

The average age of the executives with a known age is 59; the youngest is 40 and the oldest 77.

Titles, ages and pay from company filings; pay for fiscal year 2025.

BBIO logo

BridgeBio Pharma, Inc.

BBIOUnited States
Healthcare

Executive Team

Dr. Neil Kumar Ph.D.

Co-Founder, CEO & Director

Age46
Total Pay$2,463,318

Dr. Thomas Trimarchi Ph.D.

CFO & President

Age40
Total Pay$1,229,882

Dr. Charles J. Homcy M.D.

Co-Founder, Chairman of Pharmaceuticals & Lead Director

Age77
Total Pay$574,167

Dr. Frank P. McCormick Ph.D.

Co-Founder, Chairman of Oncology & Director

Age75
Total Pay$550,000

Ms. Maricel M. Apuli

Chief Accounting Officer

Age48

Dr. Uma Sinha Ph.D.

Chief Scientific Officer

Age67
Total Pay$1,313,457

Dr. Richard H. Scheller Ph.D.

Chairman of Research & Development

Age72
Total Pay$509,622

Mr. Eli M. Wallace Ph.D.

Chief Scientific Officer of Oncology

Age58

Dr. Eric Michael David J.D., M.D., Ph.D.

Chief Executive Officer of Gene Therapy

Age53

Mr. Matthew Outten CPC, MBA

Chief Commercial Officer

Age51

BridgeBio Pharma executive pay, fiscal year 2025

ExecutiveTitleAgeTotal pay
Neil Kumar Ph.D.Co-Founder, CEO & Director46$2.46 million
Uma Sinha Ph.D.Chief Scientific Officer67$1.31 million
Thomas Trimarchi Ph.D.CFO & President40$1.23 million
Charles J. Homcy M.D.Co-Founder, Chairman of Pharmaceuticals & Lead Director77$574,167
Frank P. McCormick Ph.D.Co-Founder, Chairman of Oncology & Director75$550,000
Richard H. Scheller Ph.D.Chairman of Research & Development72$509,622

Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.

Questions and answers

Who is the CEO of BridgeBio Pharma?

Neil Kumar Ph.D. (Co-Founder, CEO & Director), age 46; total pay in fiscal year 2025 was $2.46 million.

Who is BridgeBio Pharma's chief financial officer?

Thomas Trimarchi Ph.D. (CFO & President), age 40.

Who is the highest-paid executive at BridgeBio Pharma?

Neil Kumar Ph.D., Co-Founder, CEO & Director, with total pay of $2.46 million in fiscal year 2025.

Who are BridgeBio Pharma's top executives?

Neil Kumar Ph.D. (Co-Founder, CEO & Director), Thomas Trimarchi Ph.D. (CFO & President), Charles J. Homcy M.D. (Co-Founder, Chairman of Pharmaceuticals & Lead Director), Frank P. McCormick Ph.D. (Co-Founder, Chairman of Oncology & Director) and Maricel M. Apuli (Chief Accounting Officer), and 5 more.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube